AHA, Concord Health Partners close $50M health tech venture round
The AHA Innovation Fund was formed to invest in early-stage healthcare companies that provide products, services and solutions that help hospitals and health systems transform care delivery, spur innovation and connect hospitals and entrepreneurs. (Getty/ipopba)
The American Hospital Association (AHA) closed a $50 million strategic venture capital fund with Concord Health Partners aimed at investing in early-stage healthcare companies.
The AHA Innovation Development Fund, or AHA Fund, is sponsored and management by Concord, which is a healthcare-focused investment firm based in New York. AHA is the anchor limited partner investor.
The fund was formed to invest in early-stage healthcare companies that provide products, services and solutions that help hospitals and health systems transform care delivery, spur innovation and connect hospitals and entrepreneurs.
Curating a Higher Level of Personalized Care: Digital Health + Mom
A long-term digital health strategy is needed to respond to the technology demands of the modern patient while thriving as an independent hospital in a fiercely competitive market. In this webinar, Overlake and one of its digital health partners, Wildflower Health, will discuss how Overlake has approached digital health and why it chose to focus early efforts on expectant moms within its patient population.
“All across the country, hospitals and health systems are innovating and transforming to meet the changing needs of their patients and their communities,” said AHA President and CEO Rick Pollack in a statement. “The AHA Fund will allow them to invest in the solutions that hospitals and health systems truly need. By finding the right business partners, the AHA Fund can help fund, guide and scale solutions offering the greatest transformational value for hospitals and health systems.”